Clinical Trial Update: Immuno-PRISM (PRecision Intervention Smoldering Myeloma) [Phase 2]

View source ↗

Summary

Phase 2 Immuno-PRISM trial evaluating a precision intervention for smoldering multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Snippet

Sponsor: Irene Ghobrial, MD | Conditions: High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Status: RECRUITING